Document is current

Article History

Accepted: 19 January 2021

First Online: 23 March 2021

Compliance with Ethical Standards

:

: Dr. Charleston has served as consultant and advisory board member or has received honoraria from AbbVie, Alder, and Biohaven. <i>He has performed </i><i>medical legal consultation for the Vaccine Injury Compensation Program</i>. He is on the advisory board of BrainWeekend and Ctrl M Health. He is an Associate Editor of Headache: The Journal of Head and Face Pain.Dr. Khalil has received research support from Eli Lilly with no conflict of interest with this manuscript.Dr. Young reports grants and personal fees from Allergan, grants and personal fees from Amgen, personal fees from Avanir, grants and personal fees from Alder (now Lundbeck), personal fees from Cipla, grants and personal fees from Eli Lilly, personal fees from Supernus, grants from Autonomic Technologies, grants from Colucid, grants from Cumberland, grants from Dr. Reddy Laboratories, grants from Novartis, grants and personal fees from PCORI, grants from Scion, grants and personal fees from Teva, grants from Zosano, personal fees from Promius, personal fees from Biohaven, personal fees from Theranica, and grants from Satsuma, outside the submitted work; he is an Advising Physician and Chairman of the Board for the Coalition for Headache and Migraine Patients (CHAMP), President for Miles for Migraine, and Co-Medical Director of Ctrl M Health.

: This article does not contain any studies with human or animal subjects performed by any of the authors.